SAM #VA-27-00000791

Sole Source Integrated Core Laboratory Solution for Atlanta VA Medical Center (Abbott Laboratories, CPRR Model)

The Department of Veterans Affairs, VISN 07, is pursuing a sole source procurement with Abbott Laboratories Inc. for an integrated core laboratory solution at the Atlanta VA Health Care System. - The acquisition uses a cost-per-reportable-result (CPRR) model, bundling all equipment, reagents, consumables, middleware, automation, and services into a single rate per verified patient result. - The solution will modernize the core laboratory through high-throughput chemistry and immunoassay testing, vendor-neutral track automation, and unified middleware/analytics. - The contract structure includes a firm-fixed price base year with four one-year option periods, following a prior task order that ends in September 2026. - The platform must include an FDA-cleared TBI blood test panel on the Alinity i analyzer and fit within specified lab space and utility constraints. - Services required include installation, interface configuration (including VistA and DI-IM), validation, staff training, and relocation of the solution. - The procurement is sole source to Abbott Laboratories Inc., with no other OEMs named, but alternative core lab solution providers may exist. - The opportunity is for the Atlanta VA Medical Center and is managed by Network Contracting Office 7.

Description

The Government requires an integrated core laboratory solution acquired under a cost‑per‑reportable‑result (CPRR) model, in which VHA is invoiced solely based on the number of reported patient test results rather than capital equipment purchases. The solution must provide high‑throughput chemistry and immunoassay testing, vendor‑neutral track automation, and unified middleware/analytics within the physical constraints of Rooms 2B‑174 and 2B‑170, while embedding all equipment, service, reagents, consumables, middleware, and automation costs into a single CPRR rate.

The requirement covers end‑to‑end core lab operations: pre‑analytic processing (centrifugation, decapping/recapping, aliquoting, routing), analytic testing (Chem/IA/ID), and post‑analytic archiving, including Indexor‑based tracking at phlebotomy and outreach sites to provide true collection‑to‑result visibility from specimen draw through result release. The digital ecosystem must support high auto verification rates, rules‑based QC management, real‑time turnaround‑time and workload dashboards, and integrated inventory management, all within the CPRR commercial structure so that AVAHCS pays only for verified reportable patient results rather than discrete hardware or service line items. The selected platform also uniquely offers an FDA‑cleared lab‑based TBI blood test panel on the core Alinity i analyzer, supporting rapid, objective concussion evaluation for Veterans within the same automated ecosystem.

Services required include installation, configuration of all required interfaces (including VistA and DI‑IM), validation, staff training, and relocation of the Phase‑2 solution into the permanent core lab in Phase 3, with these implementation and support activities treated as covered deliverables under the CPRR agreement. Essential physical characteristics include the ability to fit a near‑complete automation line into ≤765 sq ft in Room 2B‑174 during Phase 2 and a high‑density integrated solution into Room 2B‑170 in Phase 3, while meeting power, HVAC, and utility constraints and avoiding major structural renovation in the temporary space.

View original listing